A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Virginia Cancer Specialists (NEXT Oncology Virginia), Fairfax

Complejo Hospitalario de Jaen, Jaén

Hospital General Universitario Gregorio Maranon, Madrid

South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jiminez Diaz, Madrid

Hospital Universitario 12 de Octubre, Madrid

IUCT Oncopole, Toulouse

Institut Bergonie, Bordeaux

Florida Cancer Specialists, Sarasota

Sarah Cannon and HCA Research Institute, Nashville

Universitaetsklinikum Essen, Essen

Hospital Clinico Universitario de Valencia, Valencia

Community Health Network, Indianapolis

University of Wisconsin, Madison

Allina Health System DBA Virginia Piper Cancer Institute, Minneapolis

Chu de Lille, Lille

Washington University School of Medicine, St Louis

Centre Leon Berard, Lyon

MD Anderson Cancer Center, Houston

University of Arizona - Cancer Center, Tucson

Dana-Farber Cancer Institute, Boston

"KEM , Evang. Kliniken Essen-Mitte gGmbH"

NEXT Oncology Barcelona, Barcelona

Hospital Universitario Vall d'Hebron, Barcelona

Beatson West of Scotland Cancer Centre, Glasgow

The Christie NHS Foundation Trust, Manchester